Abstract PS12-23: Development of H3B-6545, a First-in-class Oral Selective ER Covalent Antagonist (SERCA), for the Treatment of ERaWT and ERaMUT Breast Cancer Manav Korpal , Craig Furman , Xiaoling Puyang , Zhaojie Zhang , Zhenhua Wu , Deepti Banka , Subhasree Das , Benoit Destenaves , Lei Gao , Erika Hamilton , Ming-Hong Hao , Sean Irwin , Stephen Johnston , Jaya J Joshi , Dejan Juric , Amy Kim , Tuong-Vi Nguyen , Marc Pipas , Timothy Pluard , Victoria Rimkunas , Nathalie Rioux , Joanne Schindler , Peter Smith , Michael Thomas , John Wang , Judy S Wang , Markus Warmuth , Huilan Yao , Shihua Yao , Lihua Yu , Frédéric H Vaillancourt , David M Bolduc , Nicholas A Larsen , GuoZhu Zheng , Sudeep Prajapati , Tarek Sahmoud , Antonio Gualberto , Ping Zhu Cancer research（2021）
AI 理解论文
溯源树
样例
